David C. Linch

1 ta ish

University College London

1. Young Adults Aged 18 to 30 Years with Hodgkin Lymphoma Can Tolerate a Modified Version of the Combined Modality German Paediatric HD95 Protocol with Minimal Neurotoxicity and Excellent Outcome. Results of the UK NCRN 18–30 Study (CRUK/08/012)

   Kirit M. Ardeshna, Peter Hoskin, Paul Smith +15

   MaqolaAcute Lymphoblastic Leukemia researchBlood20120 iqtibos

   ABIABI:AkademIndex/2012.article.000478